Dr. Glass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd Ne
Atlanta, GA 30322Phone+1 404-778-3444
Education & Training
Johns Hopkins UniversityFellowship, Neuropathology, 1989 - 1991- Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
University of MarylandInternship, Internal Medicine, 1985 - 1986
University of Vermont College of MedicineClass of 1985
Certifications & Licensure
GA State Medical License 1996 - 2025
NC State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
MD State Medical License 1989 - 1996- American Board of Pathology Neuropathology
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Atlanta Magazine: Top Doctors Castle Connolly, 2005, 2007, 2009-2014
- Super Doctor SuperDoctors.com
Clinical Trials
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Start of enrollment: 2011 Nov 01
- Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Oct 01
- Answer ALS: Individualized Initiative for ALS Discovery Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- ALSUntangled #76: Wahls protocol.Xiaoyan Li, Paul Wicks, Andrew Brown, Akhil Shivaprasad, Maxwell Greene
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-10-09 - Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised,...Leonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, Suma Babu, Michael Benatar
The Lancet. Neurology. 2024-09-01 - Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.Sarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, Olubunmi Abel, Keith Mayl
Nature Communications. 2024-07-02
Press Mentions
Experimental Treatment Could Be ‘Game-Changing’ for Genetic ALS, Experts SayMay 2nd, 2019
ALS Patients Losing Time and Hope as They Wait for Insurers to Cover a Pricey New DrugMay 21st, 2018
Cellular Traffic Jam Seen in ALS/FTDJanuary 9th, 2018- Join now to see all
Grant Support
- Neuropathology CoreNational Institute On Aging2010–2012
- Proteomic Markers For ALSNational Institute Of Neurological Disorders And Stroke2007–2008
- Discovering Calpain Inhibitors For Neurological DiseasesNational Institute On Drug Abuse2007
- Axonal Protection For Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2006–2007
- UV Light And The Cutaneous Neurosensory SystemNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002
- Mechanisms Of Axonal DegenerationNational Institute Of Neurological Disorders And Stroke2000–2002
- Core--HistologyNational Institute Of Neurological Disorders And Stroke2000–2002
- Neuroma Resection And AdriamycinEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–2000
- Calpains In The Pathogenesis Of Diabetic NeuropathyNational Institute Of Neurological Disorders And Stroke1998–1999
- Molecular Mechanisms Of Intestinal Iron TransportNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1998
- Core--NeuropathologyNational Institute Of Neurological Disorders And Stroke1997
- Iron Metabolism In Erythroid CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
- Mechanisms Of Axonal Degeneration And RegenerationNational Institute Of Neurological Disorders And Stroke1996
- Mechanisms Of Axonal Degeneration And RegenerationNational Institute Of Neurological Disorders And Stroke1992–1995
- Iron Metabolism In Erythroid CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Iron Metabolism In Erythroid Cells And HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1990
- Hemin Transport Into Differentiating Leukemic CellsNational Cancer Institute1985–1987
- Iron Metabolism In Erythroid Cells And HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1986
- Iron Metabolism In Erythroid Cells And HepatocytesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
